-+ 0.00%
-+ 0.00%
-+ 0.00%

Edgewise Therapeutics grants inducement stock options for 266,000 shares at $30.96 each

PUBT·05/04/2026 12:03:18
Listen to the news
Edgewise Therapeutics grants inducement stock options for 266,000 shares at $30.96 each
  • Edgewise Therapeutics granted inducement stock options covering 266,000 common shares to nine new non-executive employees on April 30, 2026 under its 2024 Inducement Equity Incentive Plan.
  • Options carry an exercise price of USD 30.96 per share, set at closing price on grant date.
  • Vesting set at 25% on one-year anniversary of each employee’s start date, then 1/48 monthly, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA48858) on May 04, 2026, and is solely responsible for the information contained therein.